The plaintiffs in the case claimed Avandia, which is used to treat Type 2 diabetes, increased the risk of cardiovascular events including heart attacks and congestive heart failure. It took almost a decade for the class-action lawsuit to finally deliver results for the plaintiffs. The company will pay $3,666,666.67 into a fund for people who suffered myocardial infarction, coronary artery …